📣 VC round data is live. Check it out!

Ercros Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ercros and similar public comparables like Itafos, Alto Ingredients, Messer Tehnogas, Natac Natural Ingredients and more.

Ercros Overview

About Ercros

Ercros SA is a chemical manufacturing company operating in basic and plastic chemicals divisions, intermediate chemicals division, and pharmaceuticals division. The company's product portfolio includes Caustic soda, Hydrochloric acid, Sodium chloride, Sodium hypochlorite, Glues and resins, Moulding compounds, Pentaerythritol, Erythromycin, Fosfomycin, Fusidic acid, among others. Its products are supplied to various industries including the chemical industry, construction, wood industry, paints, food industry, pharmaceuticals, electric material, and water treatment. The majority of the revenue is derived from the sale of basic chemicals in the local markets.


Founded

1904

HQ

Spain

Employees

1.3K

Website

ercros.es

Sectors

Financials (LTM)

Revenue: $779M
EBITDA: $12M

EV

$515M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ercros Financials

Ercros reported last 12-month revenue of $779M and EBITDA of $12M.

In the same LTM period, Ercros generated $277M in gross profit, $12M in EBITDA, and had net loss of ($50M).

Revenue (LTM)


Ercros P&L

In the most recent fiscal year, Ercros reported revenue of $779M and EBITDA of $8M.

Ercros is unprofitable as of last fiscal year, with gross margin of 49%, EBITDA margin of 1%, and net margin of (8%).

See analyst estimates for Ercros
LTMLast FY202320242025202620272028
Revenue$779M$779M$833M$758M$738M
Gross Profit$277M$378M$250M$236M$378M
Gross Margin36%49%30%31%51%
EBITDA$12M$8M$51M$31M$8M
EBITDA Margin1%1%6%4%1%
EBIT Margin(4%)(4%)2%(0%)(4%)
Net Profit($50M)($63M)$32M($14M)($63M)
Net Margin(6%)(8%)4%(2%)(9%)
Net Debt—$135M———

Financial data powered by Morningstar, Inc.

Ercros Stock Performance

Ercros has current market cap of $365M, and enterprise value of $515M.

Market Cap Evolution


Ercros' stock price is $3.99.

Ercros share price increased by 0.1% in the last 30 days, and by 17.2% in the last year.

Ercros has an EPS (earnings per share) of $-0.69.

See more trading valuation data for Ercros
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$515M$365M0.1%0.1%4.7%17.2%$-0.69

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ercros Valuation Multiples

Ercros trades at 0.7x EV/Revenue multiple, and 44.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Ercros

EV / Revenue (LTM)


Ercros Financial Valuation Multiples

As of May 13, 2026, Ercros has market cap of $365M and EV of $515M.

Ercros has a P/E ratio of (7.3x).

LTMLast FY202320242025202620272028
EV/Revenue0.7x0.7x0.6x0.7x0.7x
EV/EBITDA44.2x64.0x10.1x16.9x64.0x
EV/EBIT(18.5x)(15.5x)27.6x(154.2x)(15.5x)
EV/Gross Profit1.9x1.4x2.1x2.2x1.4x
P/E(7.3x)(5.8x)11.2x(26.6x)(5.8x)
EV/FCF(26.8x)21.8x10.8x(108.1x)21.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ercros Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ercros Margins & Growth Rates

Ercros decreased revenue by 0% but EBITDA grew by 147% in the last fiscal year.

In the most recent fiscal year, Ercros reported gross margin of 49%, EBITDA margin of 1%, and net margin of (8%).

See estimated margins and future growth rates for Ercros

Ercros Margins

Last FY202420252026202720282029
Gross Margin49%31%51%37%
EBITDA Margin1%4%1%3%
EBIT Margin(4%)(0%)(4%)(2%)
Net Margin(8%)(2%)(9%)(3%)
FCF Margin3%(1%)3%(6%)

Ercros Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(0%)(9%)(3%)5%
Gross Profit Growth(25%)(6%)60%(25%)
EBITDA Growth147%(40%)(74%)147%
EBIT Growth(44%)(118%)893%(44%)
Net Profit Growth(58%)(142%)360%(58%)
FCF Growth(284%)(110%)(595%)(284%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Ercros Operational KPIs

Ercros' revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.3M for the same period.

Ercros' Rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Ercros' Rule of X is 16% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Ercros
LTMLast FY202320242025202620272028
Rule of 404%8%———
Bessemer Rule of X8%16%———
Revenue per Employee—$0.6M———
Opex per Employee—$0.3M———
S&M Expenses to Revenue——0%0%—
G&A Expenses to Revenue——1%2%—
R&D Expenses to Revenue——0%0%—
Opex to Revenue—53%28%32%56%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Ercros Competitors

Ercros competitors include Itafos, Alto Ingredients, Messer Tehnogas, Natac Natural Ingredients, Oxiquim, PCC Rokita, Valhi, Samyang Holdings, Uzin Utz and Gevo.

Most Ercros public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Itafos0.7x0.7x2.1x2.6x
Alto Ingredients0.5x0.5x8.8x8.2x
Messer Tehnogas1.1x—3.0x—
Natac Natural Ingredients7.9x6.9x26.6x21.6x
Oxiquim1.5x—9.5x—
PCC Rokita1.0x1.0x7.1x6.8x
Valhi0.4x0.4x10.6x—
Samyang Holdings0.3x—3.2x—

This data is available for Pro users. Sign up to see all Ercros competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ercros

When was Ercros founded?Ercros was founded in 1904.
Where is Ercros headquartered?Ercros is headquartered in Spain.
How many employees does Ercros have?As of today, Ercros has over 1K employees.
Is Ercros publicly listed?Yes, Ercros is a public company listed on Bolsa de Madrid.
What is the stock symbol of Ercros?Ercros trades under ECR ticker.
When did Ercros go public?Ercros went public in 1990.
Who are competitors of Ercros?Ercros main competitors include Itafos, Alto Ingredients, Messer Tehnogas, Natac Natural Ingredients, Oxiquim, PCC Rokita, Valhi, Samyang Holdings, Uzin Utz, Gevo.
What is the current market cap of Ercros?Ercros' current market cap is $365M.
What is the current revenue of Ercros?Ercros' last 12 months revenue is $779M.
What is the current revenue growth of Ercros?Ercros revenue growth (NTM/LTM) is 3%.
What is the current EV/Revenue multiple of Ercros?Current revenue multiple of Ercros is 0.7x.
Is Ercros profitable?Yes, Ercros is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Ercros?Ercros' last 12 months EBITDA is $12M.
What is Ercros' EBITDA margin?Ercros' last 12 months EBITDA margin is 1%.
What is the current EV/EBITDA multiple of Ercros?Current EBITDA multiple of Ercros is 44.2x.
What is the current FCF of Ercros?Ercros' last 12 months FCF is ($19M).
What is Ercros' FCF margin?Ercros' last 12 months FCF margin is (2%).
What is the current EV/FCF multiple of Ercros?Current FCF multiple of Ercros is (26.8x).
How many companies Ercros has acquired to date?Ercros hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Ercros has invested to date?Ercros hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Ercros

Lists including Ercros

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial